FDA Approves Treatment for Children and Teens With Mildly to
FDA Approves Treatment for Children and Teens With Mildly to Moderately Active Ulcerative Colitis
FDA today approved Colazal (balsalazide disodium) for the treatment of mildly to moderately active ulcerative colitis in patients 5 to 17 years of age.